Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/25/2006EP1713466A2 Antiparasitic composition containing an organic amine salt of closantel
10/25/2006EP1713465A2 Compounds and compositions as lxr modulators
10/25/2006EP1713464A2 Glycine and/or proline for use in cartilage affecting conditions
10/25/2006EP1713463A2 Reelin deficiency or dysfunction and methods related thereto
10/25/2006EP1713462A1 A method of modulating pro-inflammatory and inflammatory activity mediated by c-reactive protein
10/25/2006EP1713461A1 Compounds having antitumor activity
10/25/2006EP1713460A2 Fk228 analogs and their use as hdac-inhibitors
10/25/2006EP1713459A2 Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases
10/25/2006EP1713458A1 Method for enhancing the bioavailability of ospemifene
10/25/2006EP1713457A2 Novel drugs and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
10/25/2006EP1713456A1 Rectal composition
10/25/2006EP1713455A2 Method for producing sorbicillactone a
10/25/2006EP1713452A2 Sustained release pharmaceutical composition of indapamide
10/25/2006EP1713451A1 Solid dosage formulations of galanthamine
10/25/2006EP1713447A1 Particulate plant sterol compositions
10/25/2006EP1713445A2 Non-lamellar compositions of dioleoyl phosphatidylethanolamine and polysorbate 80
10/25/2006EP1713444A1 A microemulsion preparation of high concentration propofol for anesthetic uses
10/25/2006EP1713443A2 Nanosuspensions of anti-retroviral agents for increased central nervous system delivery
10/25/2006EP1713439A1 Pharmaceutical preparation for the oral cavity
10/25/2006EP1713337A2 Modulation of line-1 reverse transcriptase
10/25/2006EP1669357A4 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof
10/25/2006EP1662965A4 Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane
10/25/2006EP1654262B1 7-azaindole derivatives as cox2 inhibitors
10/25/2006EP1590346B1 4- {'3-(sulfonylamino) phenyl] '1-(cyclymethyl) piperidin-4-ylidene] methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
10/25/2006EP1567501B1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
10/25/2006EP1562609B1 Inositolized phospholipids
10/25/2006EP1560830B1 Derivatives of [6, 7-dihydro-5h-imidazo[1,2 - a]imidazole -3 -sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins
10/25/2006EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase
10/25/2006EP1532152B1 Novel polymorph of n-methyl-n-(3- 3- 2-thienylcarbonyl|-pyrazol- 1,5-alpha|-pyrimidin-7-yl phenyl)acetamide and compositions and methods related thereto
10/25/2006EP1524971B1 Improved transdermal delivery system
10/25/2006EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
10/25/2006EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
10/25/2006EP1509231A4 Peritoneal dialysis solution with taurolidine
10/25/2006EP1501925A4 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis
10/25/2006EP1490030B1 Nanoparticulate compositions of angiogenesis inhibitors
10/25/2006EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
10/25/2006EP1420880A4 Stabilization and terminal sterilization of phospholipid formulations
10/25/2006EP1416949B1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba
10/25/2006EP1401824B1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors
10/25/2006EP1401416B1 Use of c-kit inhibitors for treating inflammatory bowel diseases (ibd)
10/25/2006EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/25/2006EP1383511B1 Calcilytic compounds
10/25/2006EP1370543B1 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
10/25/2006EP1363951B1 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
10/25/2006EP1332155B1 Immunization of dairy cattle with gapc protein against streptococcus infection
10/25/2006EP1326617B9 Use of 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-one for the preparation of a medicament for the treatment fo breast, ovarian, endometrial cancer, myeloma and meningioma
10/25/2006EP1315721B1 A thiazolidinedione derivative and its use as antidiabetic
10/25/2006EP1315488B1 Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions
10/25/2006EP1313476B1 Sgk3 used as diagnostic and therapeutic target
10/25/2006EP1286672B1 S-methyl-dihydro-ziprasidone for the treatment of ocular disorders.
10/25/2006EP1278522B1 Pde-v inhibitors for treatment of parkinson's disease
10/25/2006EP1265849B1 Compounds and methods to treat alzheimer's disease
10/25/2006EP1265606B1 Cell adhesion inhibitors
10/25/2006EP1219632B1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds
10/25/2006EP1187613B9 Amide substituted imidazoquinolines
10/25/2006EP1157006B1 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
10/25/2006EP1143930B1 Pharmaceutical formulation of fluticasone propionate
10/25/2006EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses
10/25/2006EP1097167B1 Neurotrophic growth factor
10/25/2006EP1089998B1 Epothilone derivatives and their synthesis and use
10/25/2006EP0912086B1 Method of screening for drugs for the treatment of alzheimer's disease
10/25/2006EP0828849B1 High-affinity oligonucleotide ligands to pdgf
10/25/2006CN1852988A Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation
10/25/2006CN1852979A Modulation of eIF4E expression
10/25/2006CN1852926A Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
10/25/2006CN1852918A Methods and compositions for interferon therapy
10/25/2006CN1852915A Purine nucleoside analogues for treating flaviviridae including hepatitis c
10/25/2006CN1852914A Novel indolopyrrolocarbazole derivative with antitumor activity
10/25/2006CN1852913A Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives
10/25/2006CN1852912A Novel 14 and 15 membered-ring compounds
10/25/2006CN1852911A Epimeridinoside A and epimeredi indica root extract preparation containing same and preparing method therefor
10/25/2006CN1852907A 2-amino-5-benzoylthiazole npy antagonists
10/25/2006CN1852905A N-substituted benzimidazolyl c-kit inhibitors
10/25/2006CN1852904A Endurance improving agent
10/25/2006CN1852901A Organic compounds
10/25/2006CN1852900A 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders
10/25/2006CN1852899A Polymorphic forms of a known antihyperlipemic agent
10/25/2006CN1852897A Gabanergic modulators
10/25/2006CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors
10/25/2006CN1852894A Crystalline forms of [R-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
10/25/2006CN1852893A (2S,4S)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-L-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
10/25/2006CN1852890A Abiotic heparin antagonists
10/25/2006CN1852881A Benzotropolone derivatives and modulation of inflammatory response
10/25/2006CN1852749A Use of dapsone as a neuroprotector in cerebral infarction
10/25/2006CN1852748A Azepine derivatives as pharmaceutical agents
10/25/2006CN1852744A Endoluminal prosthesis comprising a therapeutic agent
10/25/2006CN1852740A Multi-arm polymer prodrugs
10/25/2006CN1852739A Pharmaceutical products comprising bisphosphonates
10/25/2006CN1852738A Treatment of gastrointestinal stromal tumors with imatinib and midostaurin
10/25/2006CN1852737A Combination of a histone deacetylase inhibitor with a death receptor ligand
10/25/2006CN1852731A Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
10/25/2006CN1852722A Methods and pharmaceutical compositions for healing wounds
10/25/2006CN1852721A Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
10/25/2006CN1852720A Pharmaceutical composition and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen agonist/antagonist
10/25/2006CN1852719A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate
10/25/2006CN1852718A 2-alkylidene-19-nor-vitamin D derivatives for the treatment of frailty, muscle damage or sarcopenia
10/25/2006CN1852717A 2-alkylidene-19-nor-vitamin d derivatives for the treatment of osteopenia or male osteoporosis
10/25/2006CN1852716A Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
10/25/2006CN1852715A Cephem compounds